Troutman Pepper Locke Represents SSI Diagnostica Group in Acquisition of Gulf Coast Scientific and Subsidiaries

NEW YORK – Troutman Pepper Locke advised SSI Diagnostica Group (SSI), a global leading developer and manufacturer of infectious disease diagnostic solutions, in its acquisition of Gulf Coast Scientific and its subsidiaries, ARJ Medical and Allora Diagnostics. The acquisition further strengthens SSI’s gastrointestinal disease testing portfolio, allowing the company to support its reference and hospital lab customers in the U.S. and beyond with a broader range of highly specialized products. Jointly, the group company will consist of nearly 600 employees across sites in Denmark, the U.S., and China. The combined company will have a total revenue of approximately $125 million. For more information, see the press release.

The Troutman Pepper Locke team that advised SSI was led by James Rosener, Deborah Spranger, Erica Stalnecker Wilson, Samantha Peruto, Chelsea MacArthur, Valentina Rivera, and Phoebe Cooper.

Troutman Pepper Locke’s leading Health Care and Life Sciences Practice encompasses the entire spectrum of health care and life sciences companies. The team collaborates across disciplines to solve complex legal challenges confronting clients, offering a full suite of corporate, intellectual property, regulatory, and litigation services. Few law firms have a comparable health care and life sciences practice, and Troutman Pepper Locke draws on its deep industry knowledge to provide the precise, holistic advice and guidance clients need throughout their business cycles.

Troutman Pepper Locke

Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.